When Psychotherapy Fails

Dandachi-FitzGerald, Brechje; Otgaar, Henry; Merckelbach, Harald

doi:10.1007/978-3-031-14332-8_16

Cited by 5 publications

(5 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The development of criteria for psychotherapy-related AEs has been aided by the identification of harmful therapies (i.e., therapies that lead to harm when applied as intended), harmful practices in therapy (i.e., malpractice), and unintended harms in otherwise helpful therapies (Dandachi-FitzGerald et al, 2022;Linden, 2013). Examples of therapies known to be potentially harmful include conversion therapy, rebirthing therapies, and critical incident stress debriefing following trauma exposure (Teachman et al, 2021).…”

Section: Aes In Context: Standards For Measuring Aes In (Non-psychede...mentioning

confidence: 99%

A framework for assessment of adverse events occurring in psychedelic-assisted therapies

Palitsky,

Kaplan,

Perna

et al. 2024

J Psychopharmacol

View full text Add to dashboard Cite

Objective: Despite considerable research examining the efficacy of psychedelic-assisted therapies (PATs) for treating psychiatric disorders, assessment of adverse events (AEs) in PAT research has lagged. Current AE reporting standards in PAT trials are poorly calibrated to features of PAT that distinguish it from other treatments, leaving many potential AEs unassessed. Methods: A multidisciplinary working group of experts involved in PAT pooled formally and informally documented AEs observed through research experience and published literature. This information was integrated with (a) current standards and practices for AE reporting in pharmacotherapy and psychotherapy trials and (b) published findings documenting post-acute dosing impacts of psychedelics on subjective states, meaning, and psychosocial health variables, to produce a set of AE constructs important to evaluate in PAT as well as recommended methods and time frames for their assessment and monitoring. Correspondence between identified potential AEs and current standards for AE assessment was examined, including the extent of coverage of identified AE constructs by 25 existing measures used in relevant research. Results: Fifty-four potential AE terms warranting systematized assessment in PAT were identified, defined, and categorized. Existing measures demonstrated substantial gaps in their coverage of identified AE constructs. Recommendations were developed for how to assess PAT AEs (including patient, clinician, and informant reports), and when to assess over preparation, dosing session, integration, and follow-up. Application of this framework is demonstrated in a preliminary assessment protocol (available in the supplement). Conclusions: This assessment framework addresses the need to capture post-acute dosing AEs in PAT, accounting for its pharmacotherapy and psychotherapy components, as well as documented impacts of psychedelics on worldviews and spirituality.

show abstract

Section: Aes In Context: Standards For Measuring Aes In (Non-psychede...mentioning

confidence: 99%

A framework for assessment of adverse events occurring in psychedelic-assisted therapies

Palitsky,

Kaplan,

Perna

et al. 2024

J Psychopharmacol

View full text Add to dashboard Cite

show abstract

“…Un autre enjeu à considérer en pratique clinique est la prévalence des profils non valides variant selon le type de population ou le contexte clinique (p. ex. Dandachi-Fitzgerald et Martin, 2022). En situation d'expertise, la prévalence de résultats non valides peut varier entre 30 et 54% selon certaines études (p. ex.…”

Section: éValuation De La Validité Chez L'adulteunclassified

“…Puisque la prévalence a un impact non négligeable sur le taux de faux positifs, comme le présente la Figure 1, l'obtention d'un échec à un TVP ne doit pas être considérée de la même façon en contexte d'expertise qu'en pratique clinique (voir Elwood, 1993, pour une explication du théorème de Bayes en neuropsychologie). Prenons un exemple fictif à la Figure 1 où l'on estime les taux d'échecs (prévalence) à un seul TVP à 40% en expertise et à 10% en pratique clinique, puisque plusieurs études empiriques démontrent un plus haut taux de base en expertise (Dandachi-Fitzgerald et Martin, 2022). En contexte d'expertise, un faux positif surviendrait dans un cas sur six chez ceux qui échouent un TVP.…”

Section: éValuation De La Validité Chez L'adulteunclassified

Validité de performance aux tests neuropsychologiques: prise de position de l’Association québécoise des neuropsychologues

Bertrand,

Chartrand,

Kennepohl

et al. 2023

NCACN

View full text Add to dashboard Cite

Traditionnellement, les neuropsychologues présumaient que les résultats obtenus lors de leurs évaluations représentaient un tableau fiable du fonctionnement cognitif de leurs clients. Or, la littérature démontre qu’une proportion non négligeable des personnes évaluées produit des résultats non valides, et ce, que ce soit dans un contexte clinique1 ou en expertise. De plus, des études suggèrent que le jugement clinique serait insuffisant pour dépister une performance non valide aux tests neuropsychologiques. Le présent article vise à définir les concepts sous-jacents concernant la validité de performance, décrire les prises de position adoptées par les associations professionnelles, faire un bref état des lieux pour les clientèles pédiatrique, adulte et gériatrique, et présenter quelques méthodes appropriées pour son évaluation. Nous recommandons que toute évaluation neuropsychologique comporte une appréciation formelle de la validité des données obtenues, minimalement avec des indices imbriqués, en utilisant des outils et méthodes reconnus.

show abstract

“…suicidal ideation after a therapy session, increased anxiety during exposure), relapse and drop‐out but also destabilization of social life (e.g. strains in family relations; Dandachi‐FitzGerald, Otgaar, and Merckelbach 2023). To develop clinical practice guidelines for psychotherapy, it is imperative that professionals have access to accurate information regarding the balance between benefits and potential drawbacks associated with these therapeutic approaches (Halfond, Wright, and Bufka 2021).…”

Section: Introductionmentioning

confidence: 99%

A Scale for Measuring Positive and Negative Experiences of Psychotherapy (PNEP): First Psychometric Findings of a New Instrument for Monitoring Clients' Experiences

Dandachi‐FitzGerald,

Houben,

Broers

et al. 2024

Clin Psychology and Psychoth

View full text Add to dashboard Cite

BackgroundClients' adverse experiences during psychotherapy are rarely monitored in clinical practice or research trials. One obstacle here is the lack of a measure to gauge both positive and negative experiences during psychotherapy. We developed and evaluated a new instrument for measuring such experiences.MethodThe Positive and Negative Experiences of Psychotherapy (PNEP) questionnaire was developed based on pilot data, a literature review, and two existing scales for measuring primarily adverse experiences during psychotherapy. Mental healthcare clients (N = 200) anonymously completed and evaluated the PNEP. Subsequently, a sample of professionals (N = 34) who underwent psychotherapy in the context of their training filled in the PNEP twice, with a 2‐week interval in between.ResultsThe positive and negative experiences subscales of the PNEP were found to possess excellent internal consistencies (αs ≥ 0.90). The PNEP test–retest reliability was 0.93 for the positive experiences subscale and 0.78 for the negative experiences subscale. For the positive subscale, four factors were extracted: symptom reduction and positive well‐being, high quality of therapy and therapeutic relation, personal growth and acceptance and interpersonal functioning. For the negative subscale, exploratory factor analysis suggested a three‐factor solution: escalation of symptoms and emotional distress, low quality of therapy and therapeutic relation and (self‐)stigmatization and dependency. Participants related a median of 13 positive and six negative therapy experiences to their most recent treatment. The most frequently endorsed negative experiences were having more negative thoughts and memories, feeling emotionally overwhelmed and an increase in stress due to the therapy. A minority of participants (10.5%) reported no negative treatment experiences.ConclusionsIn the field of psychotherapy, the evaluation of risks and benefits is crucial for assessing safety and effectiveness. The PNEP could be a promising instrument for achieving this objective, although further research is needed to replicate and expand upon the current findings.

show abstract

When Psychotherapy Fails

Cited by 5 publications

References 54 publications

A framework for assessment of adverse events occurring in psychedelic-assisted therapies

A framework for assessment of adverse events occurring in psychedelic-assisted therapies

Validité de performance aux tests neuropsychologiques: prise de position de l’Association québécoise des neuropsychologues

A Scale for Measuring Positive and Negative Experiences of Psychotherapy (PNEP): First Psychometric Findings of a New Instrument for Monitoring Clients' Experiences

Contact Info

Product

Resources

About